Thumbnail Image
Publication

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.

Gollins, S
; 
West, N
; 
Sebag-Montefiore, D
; 
Myint, A
; 
Saunders, Mark P
; 
Susnerwala, S
; 
Quirke, P
; 
Essapen, S
; 
Samuel, L
; 
Sizer, B
... show 10 more
Citations
Altmetric:
Abstract
The influence of EGFR pathway mutations on cetuximab-containing rectal cancer preoperative chemoradiation (CRT) is uncertain.
Authors
Gollins, S
West, N
Sebag-Montefiore, D
Myint, A
Saunders, Mark P
Susnerwala, S
Quirke, P
Essapen, S
Samuel, L
Sizer, B
Worlding, J
Southward, K
Hemmings, G
Tinkler-Hundal, E
Taylor, M
Bottomley, D
Chambers, P
Lawrie, E
Lopes, A
Beare, S
Affiliation
Department of Oncology, North Wales Cancer Treatment Centre, Bodelwyddan, Denbighshire LL18 5UJ
Description
Date
2017-08-31
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Full text open access article
Adobe PDF, 289.94 KB
Keywords
Type
Article
Citation
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. 2017 Br J Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620582
Embedded videos